|Values are valid only on day of printing.|
Establishing a diagnosis of a plasma cell proliferative disorder
Providing prognostic information for newly diagnosed multiple myeloma and other plasma cell proliferative disorders
Assessing response to therapy and detecting disease relapse and progression in treated plasma cell proliferative disorder patients
Determining plasma cell DNA content and proliferation
|Test ID||Reporting Name||Available Separately||Always Performed|
|FCINT||Flow Cytometry Interp, 2-8 Markers||No, (Bill Only)||Yes|
When this test is ordered, flow cytometry interpretation will always be performed at an additional charge.
See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
Flow Cytometry/DNA Content/Cell Cycle Analysis